Cochrane Abstracts
Pentoxifylline for diabetic kidney disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pentoxifylline for Diabetic Kidney Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432944/all/Pentoxifylline_for_diabetic_kidney_disease.
Pentoxifylline for diabetic kidney disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432944/all/Pentoxifylline_for_diabetic_kidney_disease. Accessed January 17, 2025.
Pentoxifylline for diabetic kidney disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432944/all/Pentoxifylline_for_diabetic_kidney_disease
Pentoxifylline for Diabetic Kidney Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432944/all/Pentoxifylline_for_diabetic_kidney_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pentoxifylline for diabetic kidney disease
ID - 432944
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432944/all/Pentoxifylline_for_diabetic_kidney_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
